Thanks, Jennifer, and good morning, everyone. Second quarter, we reported normalized FFO of $12.1 million or $0.05 per share, flat from the first quarter, but an improvement of $0.09 per share from the second quarter of 2022. Adjusted EBITDA increased 30% from the prior year to $62.1 million, but is down 1% from the first quarter. Our consolidated cash basis NOI increased $20.2 million or 46% from the second quarter of last year to approximately $64.3 million. This increase was primarily attributable to improvements in our SHOP segment, which had an increase of $16.4 million of cash basis NOI. Occupancy in our SHOP segment increased 420 basis points since the second quarter of last year and 90 basis points since the first quarter of 2023. Average monthly rates increased 7.3% year-over-year but decreased slightly 60 basis points sequentially. The year-over-year increases in occupancy and rates resulted in a 13.7% increase in SHOP revenues, while property operating expenses increased 7.3%. The margin improved 540 basis points year-over-year but only 180 basis points sequentially. For the second quarter, 148 of our communities produced positive NOI of $34.4 million and 82 communities produced negative NOI of $11.3 million. While the number of positive NOI producing communities has increased by 20% from last quarter, we noted 101 communities had decreased NOI in the second quarter compared to the first quarter. The decrease of NOI in these communities is illustrative of the uneven and unpredictable recovery of this portfolio. Labor continues to be our largest SHOP cost at nearly 52% of revenue. And while we have seen improvements in decreasing contract labor, we are seeing the need to adjust wages to be in line with market in many of our communities. Competition for top talent remains fierce and our operators need our support to continue to improve the workforce at our communities. Similarly, our insurance costs are increasing significantly and will be a headwind moving forward. Interest expense was $47.4 million for the second quarter, representing a 15% reduction from a year ago, attributable to the $500 million prepayment of 9.75% senior notes in June of 2022, partially offset by higher interest on our credit facility, which had a weighted average interest rate of 8.1% for the quarter. As previously disclosed, in late June, the administrative agent of our credit facility notified us they had completed new appraisals of the 61 medical office and life science properties, securing the facility and determined the value it decreased, resulting in a nonmonetary default. We have since received a waiver of this default through September 30, 2023, allowing us time to complete the merger. Also, as previously stated, for more than 2 years, we have not been in compliance with our consolidated income available for debt service incurrence covenant, which prevents us from issuing any new debt or even refinancing existing debt, while the ratio, which is currently 1.08x remains below the 1.5x required. As of June 30, 2023, we had $700 million of debt maturing in the next 12 months and approximately $357 million of cash and restricted cash. We note that our SHOP segment has begun to improve, but after consultation with our operators, we expect that SHOP NOI in the second half of this year will be approximately equal to the first. We continue to expect that DHC will not be in compliance with the statin current covenants until midyear 2024 at the earliest, which is too late to address our upcoming debt maturities. Pending merger with OPI will result in a combined company that will immediately be in compliance with its financial covenants and be able to refinance maturing debt. The merger will be immediately accretive to FFO for DHC shareholders and provide an annualized dividend of $1 per combined company share. If the merger does not close, we will be forced to defer capital investment in our portfolio significantly delaying the turnaround of our SHOP segment, and we will be forced to raise expensive rescue financing, which would be dilutive to DHT shareholders. For these reasons, along with other benefits, we are actively working towards closing the merger and remain committed to executing our business plan to create long-term value. We are confident that the merger with OPI will provide the necessary liquidity and financial flexibility to address all near-term debt maturities and better position our shareholders to benefit from the combined company's long-term growth. That concludes our prepared remarks. Operator, please open up the line for questions.